After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more

StreetInsider2021-12-16

After-Hours Stock Movers: IronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

SanWangtikup
2021-12-16
SanWangtikup
[Smile]
lewisleeks
2021-12-16
lewisleeks
Nice[Smile] [Smile]
Jloong
2021-12-16
Jloong
O
- Jloong:
  K
Ting2163
2021-12-16
Ting2163
Thanks for the information. Can make as my watchlist.
kenong62
2021-12-16
kenong62
Ok done
- ocean_wave:
  [强]
kctan
2021-12-16
kctan
Like please
- JeremyKok:
  hi. please like and comment back. thank you.
- JenneyJJ:
  Done, pls like and comment in return. Thanks
- TJTan:
  liked
- Newbie_21:
  Ok
- KYLeong:
  Liked

发表看法

178

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2191997591?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-16 07:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2191997591","market":"us","top_or_hot":-1,"title":"After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more","media":"StreetInsider","content":"<div>\n<p>After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19357773\">网页链接</a>\n\n</div>\n","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19357773><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19357773\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4166","symbol_name":"消费信贷","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=19357773","article_id":"2191997591","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2191997591","pubTimestamp":1639611085,"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse ","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4166":"消费信贷","SNDX":"Syndax Pharmaceuticals, Inc. ","VRCA":"Verrica Pharmaceuticals Inc.","LEN":"莱纳建筑公司","BK4504":"桥水持仓","NAVB":"Navidea生物制药","BK4088":"住宅建筑","BK4097":"系统软件","FOCS":"Focus Financial Partners Inc.","NDSN":"Nordson Corporation","GOEV":"Canoo Inc.","SYF":"Synchrony Financial","V":"Visa","BK4561":"索罗斯持仓"},"translate_title":"下班后的股票搬运工:IronNet、Verrica Pharmaceuticals、Canoo等","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FOCS":0.9,"GOEV":0.9,"IRNT":0.9,"LEN":0.9,"NAVB":0.9,"NDSN":0.9,"SNDX":0.9,"SYF":0.9,"V":0.9,"VRCA":0.9},"content_text":"After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $11.79 million.\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 13% HIGHER; announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.\nNavidea Biopharmaceuticals, Inc. (NYSE: NAVB) 9.5% HIGHER; announced that it has terminated the Stock Purchase Agreement that was executed on August 30, 2020.\nSyndax Pharmaceuticals, Inc. (Nasdaq: SNDX) 6.7% LOWER; announced that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering\nCanoo(Nasdaq: GOEV) 6% HIGHER;announced that it was accelerating its production plans in the United States while ending its deal for VDL Nedcar in Netherlands to serve as its contract manufacturer in Europe.\nLennar Corp. (NYSE: LEN) 5.6% LOWER; reported Q4 EPS of $4.36, ex-items, $0.21 better than the analyst estimate of $4.15. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.2 billion.\nSynchrony Financial (NYSE: SYF) 1.7% HIGHER; announced today that its Board of Directors has increased the Company's share repurchase authorization by $1.0 billion. The Company had $1.2 billion remaining under its prior authorization as of September 30, 2021, so this increase will bring the amount available to $2.2 billion through the period ending June 30, 2022.\nFocus Financial Partners Inc. (NASDAQ: FOCS) 1% LOWER; launched an underwritten offering (the \"Offering\") of 3,204,448 shares of its Class A common stock. This amount includes 2,500,000 shares being offered by Focus for its own account and 704,448 shares being offered by Focus on behalf of certain of the existing unitholders of Focus Financial Partners, LLC (\"Focus LLC\"), its operating subsidiary. Focus intends to grant the underwriters a 30-day option to purchase up to an additional 480,667 shares of Focus' Class A common stock.\nNordson Corp. (NASDAQ: NDSN) 2.9% LOWER; reported Q4 EPS of $1.88, $0.21 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $599 million versus the consensus estimate of $617.45 million. Nordson Corp. sees Q1 2022 EPS of $1.80-$1.95, versus the consensus of $1.71. First quarter 2022 sales growth of 14% to 16% over prior year first quarter. Fiscal 2022 sales growth of 6% to 10% and earnings growth of 8% to 18% over the record fiscal 2021 results\nVisa (NYSE: V) 1% HIGHER; the board of directors of Visa Inc. authorized a new $12.0 billion share repurchase program.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":690936628,"gmtCreate":1639620144156,"gmtModify":1639620243162,"author":{"id":"4087452914358580","authorId":"4087452914358580","name":"SanWangtikup","avatar":"https://static.tigerbbs.com/c7f061d50a9f915d0ce8e8c879871960","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690936628","repostId":2191997591,"repostType":4,"repost":{"id":"2191997591","pubTimestamp":1639611085,"share":"https://www.laohu8.com/m/news/2191997591?lang=&edition=full","pubTime":"2021-12-16 07:31","market":"us","language":"en","title":"After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2191997591","media":"StreetInsider","summary":"After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse ","content":"<p>After-Hours Stock Movers:</p>\n<p>IronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $11.79 million.</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 13% HIGHER; announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.</p>\n<p><a href=\"https://laohu8.com/S/NAVB\">Navidea Biopharmaceuticals</a>, Inc. (NYSE: NAVB) 9.5% HIGHER; announced that it has terminated the Stock Purchase Agreement that was executed on August 30, 2020.</p>\n<p><a href=\"https://laohu8.com/S/SNDX\">Syndax Pharmaceuticals, Inc. </a>(Nasdaq: SNDX) 6.7% LOWER; announced that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering</p>\n<p>Canoo(Nasdaq:&nbsp;GOEV)&nbsp;6%&nbsp;HIGHER;announced that&nbsp;it was accelerating its production plans in the United States while ending its deal for VDL Nedcar in Netherlands to serve as its contract manufacturer in Europe.</p>\n<p>Lennar Corp. (NYSE: LEN) 5.6% LOWER; reported Q4 EPS of $4.36, ex-items, $0.21 better than the analyst estimate of $4.15. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.2 billion.</p>\n<p><a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a> (NYSE: SYF) 1.7% HIGHER; announced today that its Board of Directors has increased the Company's share repurchase authorization by $1.0 billion. The Company had $1.2 billion remaining under its prior authorization as of September 30, 2021, so this increase will bring the amount available to $2.2 billion through the period ending June 30, 2022.</p>\n<p><a href=\"https://laohu8.com/S/FOCS\">Focus Financial Partners Inc.</a> (NASDAQ: FOCS) 1% LOWER; launched an underwritten offering (the \"Offering\") of 3,204,448 shares of its Class A common stock. This amount includes 2,500,000 shares being offered by Focus for its own account and 704,448 shares being offered by Focus on behalf of certain of the existing unitholders of Focus Financial Partners, LLC (\"Focus LLC\"), its operating subsidiary. Focus intends to grant the underwriters a 30-day option to purchase up to an additional 480,667 shares of Focus' Class A common stock.</p>\n<p>Nordson Corp. (NASDAQ: NDSN) 2.9% LOWER; reported Q4 EPS of $1.88, $0.21 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $599 million versus the consensus estimate of $617.45 million. Nordson Corp. sees Q1 2022 EPS of $1.80-$1.95, versus the consensus of $1.71. First quarter 2022 sales growth of 14% to 16% over prior year first quarter. Fiscal 2022 sales growth of 6% to 10% and earnings growth of 8% to 18% over the record fiscal 2021 results</p>\n<p><a href=\"https://laohu8.com/S/V\">Visa</a> (NYSE: V) 1% HIGHER; the board of directors of Visa Inc. authorized a new $12.0 billion share repurchase program.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19357773><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19357773\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FOCS":"Focus Financial Partners Inc.","VRCA":"Verrica Pharmaceuticals Inc.","BK4097":"系统软件","SNDX":"Syndax Pharmaceuticals, Inc. ","BK4561":"索罗斯持仓","LEN":"莱纳建筑公司","BK4166":"消费信贷","NAVB":"Navidea生物制药","SYF":"Synchrony Financial","BK4504":"桥水持仓","BK4088":"住宅建筑","V":"Visa","NDSN":"Nordson Corporation","GOEV":"Canoo Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19357773","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191997591","content_text":"After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $11.79 million.\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 13% HIGHER; announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.\nNavidea Biopharmaceuticals, Inc. (NYSE: NAVB) 9.5% HIGHER; announced that it has terminated the Stock Purchase Agreement that was executed on August 30, 2020.\nSyndax Pharmaceuticals, Inc. (Nasdaq: SNDX) 6.7% LOWER; announced that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering\nCanoo(Nasdaq: GOEV) 6% HIGHER;announced that it was accelerating its production plans in the United States while ending its deal for VDL Nedcar in Netherlands to serve as its contract manufacturer in Europe.\nLennar Corp. (NYSE: LEN) 5.6% LOWER; reported Q4 EPS of $4.36, ex-items, $0.21 better than the analyst estimate of $4.15. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.2 billion.\nSynchrony Financial (NYSE: SYF) 1.7% HIGHER; announced today that its Board of Directors has increased the Company's share repurchase authorization by $1.0 billion. The Company had $1.2 billion remaining under its prior authorization as of September 30, 2021, so this increase will bring the amount available to $2.2 billion through the period ending June 30, 2022.\nFocus Financial Partners Inc. (NASDAQ: FOCS) 1% LOWER; launched an underwritten offering (the \"Offering\") of 3,204,448 shares of its Class A common stock. This amount includes 2,500,000 shares being offered by Focus for its own account and 704,448 shares being offered by Focus on behalf of certain of the existing unitholders of Focus Financial Partners, LLC (\"Focus LLC\"), its operating subsidiary. Focus intends to grant the underwriters a 30-day option to purchase up to an additional 480,667 shares of Focus' Class A common stock.\nNordson Corp. (NASDAQ: NDSN) 2.9% LOWER; reported Q4 EPS of $1.88, $0.21 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $599 million versus the consensus estimate of $617.45 million. Nordson Corp. sees Q1 2022 EPS of $1.80-$1.95, versus the consensus of $1.71. First quarter 2022 sales growth of 14% to 16% over prior year first quarter. Fiscal 2022 sales growth of 6% to 10% and earnings growth of 8% to 18% over the record fiscal 2021 results\nVisa (NYSE: V) 1% HIGHER; the board of directors of Visa Inc. authorized a new $12.0 billion share repurchase program.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":690072385,"gmtCreate":1639617754370,"gmtModify":1639617754847,"author":{"id":"4089010444435920","authorId":"4089010444435920","name":"lewisleeks","avatar":"https://static.tigerbbs.com/d39cf835a09bdd21dce8a780b993940c","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Nice[Smile]&nbsp;[Smile]&nbsp;","listText":"Nice[Smile]&nbsp;[Smile]&nbsp;","text":"Nice[Smile] [Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690072385","repostId":2191997591,"repostType":4,"repost":{"id":"2191997591","pubTimestamp":1639611085,"share":"https://www.laohu8.com/m/news/2191997591?lang=&edition=full","pubTime":"2021-12-16 07:31","market":"us","language":"en","title":"After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2191997591","media":"StreetInsider","summary":"After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse ","content":"<p>After-Hours Stock Movers:</p>\n<p>IronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $11.79 million.</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 13% HIGHER; announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.</p>\n<p><a href=\"https://laohu8.com/S/NAVB\">Navidea Biopharmaceuticals</a>, Inc. (NYSE: NAVB) 9.5% HIGHER; announced that it has terminated the Stock Purchase Agreement that was executed on August 30, 2020.</p>\n<p><a href=\"https://laohu8.com/S/SNDX\">Syndax Pharmaceuticals, Inc. </a>(Nasdaq: SNDX) 6.7% LOWER; announced that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering</p>\n<p>Canoo(Nasdaq:&nbsp;GOEV)&nbsp;6%&nbsp;HIGHER;announced that&nbsp;it was accelerating its production plans in the United States while ending its deal for VDL Nedcar in Netherlands to serve as its contract manufacturer in Europe.</p>\n<p>Lennar Corp. (NYSE: LEN) 5.6% LOWER; reported Q4 EPS of $4.36, ex-items, $0.21 better than the analyst estimate of $4.15. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.2 billion.</p>\n<p><a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a> (NYSE: SYF) 1.7% HIGHER; announced today that its Board of Directors has increased the Company's share repurchase authorization by $1.0 billion. The Company had $1.2 billion remaining under its prior authorization as of September 30, 2021, so this increase will bring the amount available to $2.2 billion through the period ending June 30, 2022.</p>\n<p><a href=\"https://laohu8.com/S/FOCS\">Focus Financial Partners Inc.</a> (NASDAQ: FOCS) 1% LOWER; launched an underwritten offering (the \"Offering\") of 3,204,448 shares of its Class A common stock. This amount includes 2,500,000 shares being offered by Focus for its own account and 704,448 shares being offered by Focus on behalf of certain of the existing unitholders of Focus Financial Partners, LLC (\"Focus LLC\"), its operating subsidiary. Focus intends to grant the underwriters a 30-day option to purchase up to an additional 480,667 shares of Focus' Class A common stock.</p>\n<p>Nordson Corp. (NASDAQ: NDSN) 2.9% LOWER; reported Q4 EPS of $1.88, $0.21 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $599 million versus the consensus estimate of $617.45 million. Nordson Corp. sees Q1 2022 EPS of $1.80-$1.95, versus the consensus of $1.71. First quarter 2022 sales growth of 14% to 16% over prior year first quarter. Fiscal 2022 sales growth of 6% to 10% and earnings growth of 8% to 18% over the record fiscal 2021 results</p>\n<p><a href=\"https://laohu8.com/S/V\">Visa</a> (NYSE: V) 1% HIGHER; the board of directors of Visa Inc. authorized a new $12.0 billion share repurchase program.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19357773><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19357773\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FOCS":"Focus Financial Partners Inc.","VRCA":"Verrica Pharmaceuticals Inc.","BK4097":"系统软件","SNDX":"Syndax Pharmaceuticals, Inc. ","BK4561":"索罗斯持仓","LEN":"莱纳建筑公司","BK4166":"消费信贷","NAVB":"Navidea生物制药","SYF":"Synchrony Financial","BK4504":"桥水持仓","BK4088":"住宅建筑","V":"Visa","NDSN":"Nordson Corporation","GOEV":"Canoo Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19357773","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191997591","content_text":"After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $11.79 million.\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 13% HIGHER; announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.\nNavidea Biopharmaceuticals, Inc. (NYSE: NAVB) 9.5% HIGHER; announced that it has terminated the Stock Purchase Agreement that was executed on August 30, 2020.\nSyndax Pharmaceuticals, Inc. (Nasdaq: SNDX) 6.7% LOWER; announced that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering\nCanoo(Nasdaq: GOEV) 6% HIGHER;announced that it was accelerating its production plans in the United States while ending its deal for VDL Nedcar in Netherlands to serve as its contract manufacturer in Europe.\nLennar Corp. (NYSE: LEN) 5.6% LOWER; reported Q4 EPS of $4.36, ex-items, $0.21 better than the analyst estimate of $4.15. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.2 billion.\nSynchrony Financial (NYSE: SYF) 1.7% HIGHER; announced today that its Board of Directors has increased the Company's share repurchase authorization by $1.0 billion. The Company had $1.2 billion remaining under its prior authorization as of September 30, 2021, so this increase will bring the amount available to $2.2 billion through the period ending June 30, 2022.\nFocus Financial Partners Inc. (NASDAQ: FOCS) 1% LOWER; launched an underwritten offering (the \"Offering\") of 3,204,448 shares of its Class A common stock. This amount includes 2,500,000 shares being offered by Focus for its own account and 704,448 shares being offered by Focus on behalf of certain of the existing unitholders of Focus Financial Partners, LLC (\"Focus LLC\"), its operating subsidiary. Focus intends to grant the underwriters a 30-day option to purchase up to an additional 480,667 shares of Focus' Class A common stock.\nNordson Corp. (NASDAQ: NDSN) 2.9% LOWER; reported Q4 EPS of $1.88, $0.21 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $599 million versus the consensus estimate of $617.45 million. Nordson Corp. sees Q1 2022 EPS of $1.80-$1.95, versus the consensus of $1.71. First quarter 2022 sales growth of 14% to 16% over prior year first quarter. Fiscal 2022 sales growth of 6% to 10% and earnings growth of 8% to 18% over the record fiscal 2021 results\nVisa (NYSE: V) 1% HIGHER; the board of directors of Visa Inc. authorized a new $12.0 billion share repurchase program.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":690021257,"gmtCreate":1639615010675,"gmtModify":1639615010752,"author":{"id":"3582461179498852","authorId":"3582461179498852","name":"Jloong","avatar":"https://static.tigerbbs.com/c4b2ad914ca2d224c8a40f6783470de6","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"O","listText":"O","text":"O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690021257","repostId":2191997591,"repostType":4,"repost":{"id":"2191997591","pubTimestamp":1639611085,"share":"https://www.laohu8.com/m/news/2191997591?lang=&edition=full","pubTime":"2021-12-16 07:31","market":"us","language":"en","title":"After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2191997591","media":"StreetInsider","summary":"After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse ","content":"<p>After-Hours Stock Movers:</p>\n<p>IronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $11.79 million.</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 13% HIGHER; announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.</p>\n<p><a href=\"https://laohu8.com/S/NAVB\">Navidea Biopharmaceuticals</a>, Inc. (NYSE: NAVB) 9.5% HIGHER; announced that it has terminated the Stock Purchase Agreement that was executed on August 30, 2020.</p>\n<p><a href=\"https://laohu8.com/S/SNDX\">Syndax Pharmaceuticals, Inc. </a>(Nasdaq: SNDX) 6.7% LOWER; announced that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering</p>\n<p>Canoo(Nasdaq:&nbsp;GOEV)&nbsp;6%&nbsp;HIGHER;announced that&nbsp;it was accelerating its production plans in the United States while ending its deal for VDL Nedcar in Netherlands to serve as its contract manufacturer in Europe.</p>\n<p>Lennar Corp. (NYSE: LEN) 5.6% LOWER; reported Q4 EPS of $4.36, ex-items, $0.21 better than the analyst estimate of $4.15. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.2 billion.</p>\n<p><a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a> (NYSE: SYF) 1.7% HIGHER; announced today that its Board of Directors has increased the Company's share repurchase authorization by $1.0 billion. The Company had $1.2 billion remaining under its prior authorization as of September 30, 2021, so this increase will bring the amount available to $2.2 billion through the period ending June 30, 2022.</p>\n<p><a href=\"https://laohu8.com/S/FOCS\">Focus Financial Partners Inc.</a> (NASDAQ: FOCS) 1% LOWER; launched an underwritten offering (the \"Offering\") of 3,204,448 shares of its Class A common stock. This amount includes 2,500,000 shares being offered by Focus for its own account and 704,448 shares being offered by Focus on behalf of certain of the existing unitholders of Focus Financial Partners, LLC (\"Focus LLC\"), its operating subsidiary. Focus intends to grant the underwriters a 30-day option to purchase up to an additional 480,667 shares of Focus' Class A common stock.</p>\n<p>Nordson Corp. (NASDAQ: NDSN) 2.9% LOWER; reported Q4 EPS of $1.88, $0.21 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $599 million versus the consensus estimate of $617.45 million. Nordson Corp. sees Q1 2022 EPS of $1.80-$1.95, versus the consensus of $1.71. First quarter 2022 sales growth of 14% to 16% over prior year first quarter. Fiscal 2022 sales growth of 6% to 10% and earnings growth of 8% to 18% over the record fiscal 2021 results</p>\n<p><a href=\"https://laohu8.com/S/V\">Visa</a> (NYSE: V) 1% HIGHER; the board of directors of Visa Inc. authorized a new $12.0 billion share repurchase program.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19357773><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19357773\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FOCS":"Focus Financial Partners Inc.","VRCA":"Verrica Pharmaceuticals Inc.","BK4097":"系统软件","SNDX":"Syndax Pharmaceuticals, Inc. ","BK4561":"索罗斯持仓","LEN":"莱纳建筑公司","BK4166":"消费信贷","NAVB":"Navidea生物制药","SYF":"Synchrony Financial","BK4504":"桥水持仓","BK4088":"住宅建筑","V":"Visa","NDSN":"Nordson Corporation","GOEV":"Canoo Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19357773","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191997591","content_text":"After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $11.79 million.\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 13% HIGHER; announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.\nNavidea Biopharmaceuticals, Inc. (NYSE: NAVB) 9.5% HIGHER; announced that it has terminated the Stock Purchase Agreement that was executed on August 30, 2020.\nSyndax Pharmaceuticals, Inc. (Nasdaq: SNDX) 6.7% LOWER; announced that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering\nCanoo(Nasdaq: GOEV) 6% HIGHER;announced that it was accelerating its production plans in the United States while ending its deal for VDL Nedcar in Netherlands to serve as its contract manufacturer in Europe.\nLennar Corp. (NYSE: LEN) 5.6% LOWER; reported Q4 EPS of $4.36, ex-items, $0.21 better than the analyst estimate of $4.15. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.2 billion.\nSynchrony Financial (NYSE: SYF) 1.7% HIGHER; announced today that its Board of Directors has increased the Company's share repurchase authorization by $1.0 billion. The Company had $1.2 billion remaining under its prior authorization as of September 30, 2021, so this increase will bring the amount available to $2.2 billion through the period ending June 30, 2022.\nFocus Financial Partners Inc. (NASDAQ: FOCS) 1% LOWER; launched an underwritten offering (the \"Offering\") of 3,204,448 shares of its Class A common stock. This amount includes 2,500,000 shares being offered by Focus for its own account and 704,448 shares being offered by Focus on behalf of certain of the existing unitholders of Focus Financial Partners, LLC (\"Focus LLC\"), its operating subsidiary. Focus intends to grant the underwriters a 30-day option to purchase up to an additional 480,667 shares of Focus' Class A common stock.\nNordson Corp. (NASDAQ: NDSN) 2.9% LOWER; reported Q4 EPS of $1.88, $0.21 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $599 million versus the consensus estimate of $617.45 million. Nordson Corp. sees Q1 2022 EPS of $1.80-$1.95, versus the consensus of $1.71. First quarter 2022 sales growth of 14% to 16% over prior year first quarter. Fiscal 2022 sales growth of 6% to 10% and earnings growth of 8% to 18% over the record fiscal 2021 results\nVisa (NYSE: V) 1% HIGHER; the board of directors of Visa Inc. authorized a new $12.0 billion share repurchase program.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6998081,"gmtCreate":1639615018370,"gmtModify":1639615018397,"authorId":3582461179498852,"author":{"id":3582461179498852,"authorId":3582461179498852,"name":"Jloong","avatar":"https://static.tigerbbs.com/c4b2ad914ca2d224c8a40f6783470de6","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":690021257,"type":1,"supId":0,"prevId":0,"content":"K","text":"K","html":"K"}],"langContent":"CN"},{"id":690087954,"gmtCreate":1639614089305,"gmtModify":1639619912791,"author":{"id":"4100171708004330","authorId":"4100171708004330","name":"Ting2163","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Thanks for the information. Can make as my watchlist.&nbsp;","listText":"Thanks for the information. Can make as my watchlist.&nbsp;","text":"Thanks for the information. Can make as my watchlist.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690087954","repostId":2191997591,"repostType":4,"repost":{"id":"2191997591","pubTimestamp":1639611085,"share":"https://www.laohu8.com/m/news/2191997591?lang=&edition=full","pubTime":"2021-12-16 07:31","market":"us","language":"en","title":"After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2191997591","media":"StreetInsider","summary":"After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse ","content":"<p>After-Hours Stock Movers:</p>\n<p>IronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $11.79 million.</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 13% HIGHER; announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.</p>\n<p><a href=\"https://laohu8.com/S/NAVB\">Navidea Biopharmaceuticals</a>, Inc. (NYSE: NAVB) 9.5% HIGHER; announced that it has terminated the Stock Purchase Agreement that was executed on August 30, 2020.</p>\n<p><a href=\"https://laohu8.com/S/SNDX\">Syndax Pharmaceuticals, Inc. </a>(Nasdaq: SNDX) 6.7% LOWER; announced that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering</p>\n<p>Canoo(Nasdaq:&nbsp;GOEV)&nbsp;6%&nbsp;HIGHER;announced that&nbsp;it was accelerating its production plans in the United States while ending its deal for VDL Nedcar in Netherlands to serve as its contract manufacturer in Europe.</p>\n<p>Lennar Corp. (NYSE: LEN) 5.6% LOWER; reported Q4 EPS of $4.36, ex-items, $0.21 better than the analyst estimate of $4.15. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.2 billion.</p>\n<p><a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a> (NYSE: SYF) 1.7% HIGHER; announced today that its Board of Directors has increased the Company's share repurchase authorization by $1.0 billion. The Company had $1.2 billion remaining under its prior authorization as of September 30, 2021, so this increase will bring the amount available to $2.2 billion through the period ending June 30, 2022.</p>\n<p><a href=\"https://laohu8.com/S/FOCS\">Focus Financial Partners Inc.</a> (NASDAQ: FOCS) 1% LOWER; launched an underwritten offering (the \"Offering\") of 3,204,448 shares of its Class A common stock. This amount includes 2,500,000 shares being offered by Focus for its own account and 704,448 shares being offered by Focus on behalf of certain of the existing unitholders of Focus Financial Partners, LLC (\"Focus LLC\"), its operating subsidiary. Focus intends to grant the underwriters a 30-day option to purchase up to an additional 480,667 shares of Focus' Class A common stock.</p>\n<p>Nordson Corp. (NASDAQ: NDSN) 2.9% LOWER; reported Q4 EPS of $1.88, $0.21 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $599 million versus the consensus estimate of $617.45 million. Nordson Corp. sees Q1 2022 EPS of $1.80-$1.95, versus the consensus of $1.71. First quarter 2022 sales growth of 14% to 16% over prior year first quarter. Fiscal 2022 sales growth of 6% to 10% and earnings growth of 8% to 18% over the record fiscal 2021 results</p>\n<p><a href=\"https://laohu8.com/S/V\">Visa</a> (NYSE: V) 1% HIGHER; the board of directors of Visa Inc. authorized a new $12.0 billion share repurchase program.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19357773><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19357773\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FOCS":"Focus Financial Partners Inc.","VRCA":"Verrica Pharmaceuticals Inc.","BK4097":"系统软件","SNDX":"Syndax Pharmaceuticals, Inc. ","BK4561":"索罗斯持仓","LEN":"莱纳建筑公司","BK4166":"消费信贷","NAVB":"Navidea生物制药","SYF":"Synchrony Financial","BK4504":"桥水持仓","BK4088":"住宅建筑","V":"Visa","NDSN":"Nordson Corporation","GOEV":"Canoo Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19357773","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191997591","content_text":"After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $11.79 million.\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 13% HIGHER; announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.\nNavidea Biopharmaceuticals, Inc. (NYSE: NAVB) 9.5% HIGHER; announced that it has terminated the Stock Purchase Agreement that was executed on August 30, 2020.\nSyndax Pharmaceuticals, Inc. (Nasdaq: SNDX) 6.7% LOWER; announced that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering\nCanoo(Nasdaq: GOEV) 6% HIGHER;announced that it was accelerating its production plans in the United States while ending its deal for VDL Nedcar in Netherlands to serve as its contract manufacturer in Europe.\nLennar Corp. (NYSE: LEN) 5.6% LOWER; reported Q4 EPS of $4.36, ex-items, $0.21 better than the analyst estimate of $4.15. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.2 billion.\nSynchrony Financial (NYSE: SYF) 1.7% HIGHER; announced today that its Board of Directors has increased the Company's share repurchase authorization by $1.0 billion. The Company had $1.2 billion remaining under its prior authorization as of September 30, 2021, so this increase will bring the amount available to $2.2 billion through the period ending June 30, 2022.\nFocus Financial Partners Inc. (NASDAQ: FOCS) 1% LOWER; launched an underwritten offering (the \"Offering\") of 3,204,448 shares of its Class A common stock. This amount includes 2,500,000 shares being offered by Focus for its own account and 704,448 shares being offered by Focus on behalf of certain of the existing unitholders of Focus Financial Partners, LLC (\"Focus LLC\"), its operating subsidiary. Focus intends to grant the underwriters a 30-day option to purchase up to an additional 480,667 shares of Focus' Class A common stock.\nNordson Corp. (NASDAQ: NDSN) 2.9% LOWER; reported Q4 EPS of $1.88, $0.21 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $599 million versus the consensus estimate of $617.45 million. Nordson Corp. sees Q1 2022 EPS of $1.80-$1.95, versus the consensus of $1.71. First quarter 2022 sales growth of 14% to 16% over prior year first quarter. Fiscal 2022 sales growth of 6% to 10% and earnings growth of 8% to 18% over the record fiscal 2021 results\nVisa (NYSE: V) 1% HIGHER; the board of directors of Visa Inc. authorized a new $12.0 billion share repurchase program.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":690010965,"gmtCreate":1639612979579,"gmtModify":1639612981770,"author":{"id":"3574928367638029","authorId":"3574928367638029","name":"kenong62","avatar":"https://static.tigerbbs.com/37fd00bd8cea11b8aa1aed6d9ddd9413","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Ok done","listText":"Ok done","text":"Ok done","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690010965","repostId":2191997591,"repostType":4,"repost":{"id":"2191997591","pubTimestamp":1639611085,"share":"https://www.laohu8.com/m/news/2191997591?lang=&edition=full","pubTime":"2021-12-16 07:31","market":"us","language":"en","title":"After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2191997591","media":"StreetInsider","summary":"After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse ","content":"<p>After-Hours Stock Movers:</p>\n<p>IronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $11.79 million.</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 13% HIGHER; announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.</p>\n<p><a href=\"https://laohu8.com/S/NAVB\">Navidea Biopharmaceuticals</a>, Inc. (NYSE: NAVB) 9.5% HIGHER; announced that it has terminated the Stock Purchase Agreement that was executed on August 30, 2020.</p>\n<p><a href=\"https://laohu8.com/S/SNDX\">Syndax Pharmaceuticals, Inc. </a>(Nasdaq: SNDX) 6.7% LOWER; announced that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering</p>\n<p>Canoo(Nasdaq:&nbsp;GOEV)&nbsp;6%&nbsp;HIGHER;announced that&nbsp;it was accelerating its production plans in the United States while ending its deal for VDL Nedcar in Netherlands to serve as its contract manufacturer in Europe.</p>\n<p>Lennar Corp. (NYSE: LEN) 5.6% LOWER; reported Q4 EPS of $4.36, ex-items, $0.21 better than the analyst estimate of $4.15. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.2 billion.</p>\n<p><a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a> (NYSE: SYF) 1.7% HIGHER; announced today that its Board of Directors has increased the Company's share repurchase authorization by $1.0 billion. The Company had $1.2 billion remaining under its prior authorization as of September 30, 2021, so this increase will bring the amount available to $2.2 billion through the period ending June 30, 2022.</p>\n<p><a href=\"https://laohu8.com/S/FOCS\">Focus Financial Partners Inc.</a> (NASDAQ: FOCS) 1% LOWER; launched an underwritten offering (the \"Offering\") of 3,204,448 shares of its Class A common stock. This amount includes 2,500,000 shares being offered by Focus for its own account and 704,448 shares being offered by Focus on behalf of certain of the existing unitholders of Focus Financial Partners, LLC (\"Focus LLC\"), its operating subsidiary. Focus intends to grant the underwriters a 30-day option to purchase up to an additional 480,667 shares of Focus' Class A common stock.</p>\n<p>Nordson Corp. (NASDAQ: NDSN) 2.9% LOWER; reported Q4 EPS of $1.88, $0.21 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $599 million versus the consensus estimate of $617.45 million. Nordson Corp. sees Q1 2022 EPS of $1.80-$1.95, versus the consensus of $1.71. First quarter 2022 sales growth of 14% to 16% over prior year first quarter. Fiscal 2022 sales growth of 6% to 10% and earnings growth of 8% to 18% over the record fiscal 2021 results</p>\n<p><a href=\"https://laohu8.com/S/V\">Visa</a> (NYSE: V) 1% HIGHER; the board of directors of Visa Inc. authorized a new $12.0 billion share repurchase program.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19357773><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19357773\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FOCS":"Focus Financial Partners Inc.","VRCA":"Verrica Pharmaceuticals Inc.","BK4097":"系统软件","SNDX":"Syndax Pharmaceuticals, Inc. ","BK4561":"索罗斯持仓","LEN":"莱纳建筑公司","BK4166":"消费信贷","NAVB":"Navidea生物制药","SYF":"Synchrony Financial","BK4504":"桥水持仓","BK4088":"住宅建筑","V":"Visa","NDSN":"Nordson Corporation","GOEV":"Canoo Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19357773","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191997591","content_text":"After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $11.79 million.\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 13% HIGHER; announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.\nNavidea Biopharmaceuticals, Inc. (NYSE: NAVB) 9.5% HIGHER; announced that it has terminated the Stock Purchase Agreement that was executed on August 30, 2020.\nSyndax Pharmaceuticals, Inc. (Nasdaq: SNDX) 6.7% LOWER; announced that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering\nCanoo(Nasdaq: GOEV) 6% HIGHER;announced that it was accelerating its production plans in the United States while ending its deal for VDL Nedcar in Netherlands to serve as its contract manufacturer in Europe.\nLennar Corp. (NYSE: LEN) 5.6% LOWER; reported Q4 EPS of $4.36, ex-items, $0.21 better than the analyst estimate of $4.15. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.2 billion.\nSynchrony Financial (NYSE: SYF) 1.7% HIGHER; announced today that its Board of Directors has increased the Company's share repurchase authorization by $1.0 billion. The Company had $1.2 billion remaining under its prior authorization as of September 30, 2021, so this increase will bring the amount available to $2.2 billion through the period ending June 30, 2022.\nFocus Financial Partners Inc. (NASDAQ: FOCS) 1% LOWER; launched an underwritten offering (the \"Offering\") of 3,204,448 shares of its Class A common stock. This amount includes 2,500,000 shares being offered by Focus for its own account and 704,448 shares being offered by Focus on behalf of certain of the existing unitholders of Focus Financial Partners, LLC (\"Focus LLC\"), its operating subsidiary. Focus intends to grant the underwriters a 30-day option to purchase up to an additional 480,667 shares of Focus' Class A common stock.\nNordson Corp. (NASDAQ: NDSN) 2.9% LOWER; reported Q4 EPS of $1.88, $0.21 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $599 million versus the consensus estimate of $617.45 million. Nordson Corp. sees Q1 2022 EPS of $1.80-$1.95, versus the consensus of $1.71. First quarter 2022 sales growth of 14% to 16% over prior year first quarter. Fiscal 2022 sales growth of 6% to 10% and earnings growth of 8% to 18% over the record fiscal 2021 results\nVisa (NYSE: V) 1% HIGHER; the board of directors of Visa Inc. authorized a new $12.0 billion share repurchase program.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6999108,"gmtCreate":1639618395793,"gmtModify":1639618395905,"authorId":3578971018458145,"author":{"id":3578971018458145,"authorId":3578971018458145,"name":"ocean_wave","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":690010965,"type":1,"supId":0,"prevId":0,"content":"[强]","text":"[强]","html":"[强]"}],"langContent":"CN"},{"id":690094596,"gmtCreate":1639612155294,"gmtModify":1639612155547,"author":{"id":"3576831123463310","authorId":"3576831123463310","name":"kctan","avatar":"https://static.tigerbbs.com/f1770830f8c002db55c8aadca0939107","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like please&nbsp;","listText":"Like please&nbsp;","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/690094596","repostId":2191997591,"repostType":4,"repost":{"id":"2191997591","pubTimestamp":1639611085,"share":"https://www.laohu8.com/m/news/2191997591?lang=&edition=full","pubTime":"2021-12-16 07:31","market":"us","language":"en","title":"After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2191997591","media":"StreetInsider","summary":"After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse ","content":"<p>After-Hours Stock Movers:</p>\n<p>IronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $11.79 million.</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 13% HIGHER; announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.</p>\n<p><a href=\"https://laohu8.com/S/NAVB\">Navidea Biopharmaceuticals</a>, Inc. (NYSE: NAVB) 9.5% HIGHER; announced that it has terminated the Stock Purchase Agreement that was executed on August 30, 2020.</p>\n<p><a href=\"https://laohu8.com/S/SNDX\">Syndax Pharmaceuticals, Inc. </a>(Nasdaq: SNDX) 6.7% LOWER; announced that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering</p>\n<p>Canoo(Nasdaq:&nbsp;GOEV)&nbsp;6%&nbsp;HIGHER;announced that&nbsp;it was accelerating its production plans in the United States while ending its deal for VDL Nedcar in Netherlands to serve as its contract manufacturer in Europe.</p>\n<p>Lennar Corp. (NYSE: LEN) 5.6% LOWER; reported Q4 EPS of $4.36, ex-items, $0.21 better than the analyst estimate of $4.15. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.2 billion.</p>\n<p><a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a> (NYSE: SYF) 1.7% HIGHER; announced today that its Board of Directors has increased the Company's share repurchase authorization by $1.0 billion. The Company had $1.2 billion remaining under its prior authorization as of September 30, 2021, so this increase will bring the amount available to $2.2 billion through the period ending June 30, 2022.</p>\n<p><a href=\"https://laohu8.com/S/FOCS\">Focus Financial Partners Inc.</a> (NASDAQ: FOCS) 1% LOWER; launched an underwritten offering (the \"Offering\") of 3,204,448 shares of its Class A common stock. This amount includes 2,500,000 shares being offered by Focus for its own account and 704,448 shares being offered by Focus on behalf of certain of the existing unitholders of Focus Financial Partners, LLC (\"Focus LLC\"), its operating subsidiary. Focus intends to grant the underwriters a 30-day option to purchase up to an additional 480,667 shares of Focus' Class A common stock.</p>\n<p>Nordson Corp. (NASDAQ: NDSN) 2.9% LOWER; reported Q4 EPS of $1.88, $0.21 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $599 million versus the consensus estimate of $617.45 million. Nordson Corp. sees Q1 2022 EPS of $1.80-$1.95, versus the consensus of $1.71. First quarter 2022 sales growth of 14% to 16% over prior year first quarter. Fiscal 2022 sales growth of 6% to 10% and earnings growth of 8% to 18% over the record fiscal 2021 results</p>\n<p><a href=\"https://laohu8.com/S/V\">Visa</a> (NYSE: V) 1% HIGHER; the board of directors of Visa Inc. authorized a new $12.0 billion share repurchase program.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: IronNet,Verrica Pharmaceuticals,Canoo and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 07:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19357773><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19357773\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FOCS":"Focus Financial Partners Inc.","VRCA":"Verrica Pharmaceuticals Inc.","BK4097":"系统软件","SNDX":"Syndax Pharmaceuticals, Inc. ","BK4561":"索罗斯持仓","LEN":"莱纳建筑公司","BK4166":"消费信贷","NAVB":"Navidea生物制药","SYF":"Synchrony Financial","BK4504":"桥水持仓","BK4088":"住宅建筑","V":"Visa","NDSN":"Nordson Corporation","GOEV":"Canoo Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19357773","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191997591","content_text":"After-Hours Stock Movers:\nIronNet (NYSE: IRNT) 19.9% LOWER; reported Q3 EPS of ($2.22), $2.07 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $11.79 million.\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 13% HIGHER; announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.\nNavidea Biopharmaceuticals, Inc. (NYSE: NAVB) 9.5% HIGHER; announced that it has terminated the Stock Purchase Agreement that was executed on August 30, 2020.\nSyndax Pharmaceuticals, Inc. (Nasdaq: SNDX) 6.7% LOWER; announced that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering\nCanoo(Nasdaq: GOEV) 6% HIGHER;announced that it was accelerating its production plans in the United States while ending its deal for VDL Nedcar in Netherlands to serve as its contract manufacturer in Europe.\nLennar Corp. (NYSE: LEN) 5.6% LOWER; reported Q4 EPS of $4.36, ex-items, $0.21 better than the analyst estimate of $4.15. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.2 billion.\nSynchrony Financial (NYSE: SYF) 1.7% HIGHER; announced today that its Board of Directors has increased the Company's share repurchase authorization by $1.0 billion. The Company had $1.2 billion remaining under its prior authorization as of September 30, 2021, so this increase will bring the amount available to $2.2 billion through the period ending June 30, 2022.\nFocus Financial Partners Inc. (NASDAQ: FOCS) 1% LOWER; launched an underwritten offering (the \"Offering\") of 3,204,448 shares of its Class A common stock. This amount includes 2,500,000 shares being offered by Focus for its own account and 704,448 shares being offered by Focus on behalf of certain of the existing unitholders of Focus Financial Partners, LLC (\"Focus LLC\"), its operating subsidiary. Focus intends to grant the underwriters a 30-day option to purchase up to an additional 480,667 shares of Focus' Class A common stock.\nNordson Corp. (NASDAQ: NDSN) 2.9% LOWER; reported Q4 EPS of $1.88, $0.21 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $599 million versus the consensus estimate of $617.45 million. Nordson Corp. sees Q1 2022 EPS of $1.80-$1.95, versus the consensus of $1.71. First quarter 2022 sales growth of 14% to 16% over prior year first quarter. Fiscal 2022 sales growth of 6% to 10% and earnings growth of 8% to 18% over the record fiscal 2021 results\nVisa (NYSE: V) 1% HIGHER; the board of directors of Visa Inc. authorized a new $12.0 billion share repurchase program.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7000161,"gmtCreate":1639621958624,"gmtModify":1639621958659,"authorId":3567307840510045,"author":{"id":3567307840510045,"authorId":3567307840510045,"name":"JeremyKok","avatar":"https://static.tigerbbs.com/01b03a485f83b6b2615fad8ac9b87bf4","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":690094596,"type":1,"supId":0,"prevId":0,"content":"hi. please like and comment back. thank you.","text":"hi. please like and comment back. thank you.","html":"hi. please like and comment back. thank you."},{"id":6997610,"gmtCreate":1639613928333,"gmtModify":1639613928420,"authorId":3573203718015318,"author":{"id":3573203718015318,"authorId":3573203718015318,"name":"JenneyJJ","avatar":"https://static.tigerbbs.com/8886c72f606e31ed1eacbf1e0fb36fef","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":690094596,"type":1,"supId":0,"prevId":0,"content":"Done, pls like and comment in return. Thanks","text":"Done, pls like and comment in return. Thanks","html":"Done, pls like and comment in return. Thanks"},{"id":6997405,"gmtCreate":1639613431155,"gmtModify":1639613431188,"authorId":3579499293913149,"author":{"id":3579499293913149,"authorId":3579499293913149,"name":"TJTan","avatar":"https://static.tigerbbs.com/8b35867ea0bdab884a0a2a77afaebc5a","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":690094596,"type":1,"supId":0,"prevId":0,"content":"liked","text":"liked","html":"liked"},{"id":6997210,"gmtCreate":1639612914488,"gmtModify":1639612914517,"authorId":3581562486795328,"author":{"id":3581562486795328,"authorId":3581562486795328,"name":"Newbie_21","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":690094596,"type":1,"supId":0,"prevId":0,"content":"<u>Ok</u>","text":"<u>Ok</u>","html":"<u>Ok</u>"},{"id":6997092,"gmtCreate":1639612617235,"gmtModify":1639612617333,"authorId":3585654473355479,"author":{"id":3585654473355479,"authorId":3585654473355479,"name":"KYLeong","avatar":"https://static.tigerbbs.com/111375adba6b10bddbeeb78b9ead7c80","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":690094596,"type":1,"supId":0,"prevId":0,"content":"Liked","text":"Liked","html":"Liked"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":178,"commentSize":8,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2191997591"}